254 related articles for article (PubMed ID: 31894424)
1. Diagnostic value of seven biomarkers for breast cancer: an overview with evidence mapping and indirect comparisons of diagnostic test accuracy.
Gao Y; Liu M; Shi S; Sun Y; Li M; Zhang M; Sheng Z; Zhang J; Tian J;
Clin Exp Med; 2020 Feb; 20(1):97-108. PubMed ID: 31894424
[TBL] [Abstract][Full Text] [Related]
2. An overview protocol of biomarkers for breast cancer detection.
Sheng Z; Wang J; Li M; Luo X; Cai R; Zhang M;
Medicine (Baltimore); 2019 Jun; 98(24):e16024. PubMed ID: 31192953
[TBL] [Abstract][Full Text] [Related]
3. Relationship between diagnostic accuracy of microRNAs for NSCLC and number of combined microRNAs: an overview with meta-analysis.
Li M; Gao Y; Shi J; Zhang Y; Zhang M; Tian J
Expert Rev Mol Diagn; 2021 Sep; 21(9):983-993. PubMed ID: 34192984
[No Abstract] [Full Text] [Related]
4. Quantitative assessment of the association between APC promoter methylation and breast cancer.
He K; Zhang L; Long X
Oncotarget; 2016 Jun; 7(25):37920-37930. PubMed ID: 27191268
[TBL] [Abstract][Full Text] [Related]
5. Detection of 14-3-3 sigma (σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosis.
Ye M; Huang T; Ying Y; Li J; Yang P; Ni C; Zhou C; Chen S
Oncotarget; 2017 Feb; 8(6):9230-9242. PubMed ID: 27999208
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers for detecting malignant pleural mesothelioma: Protocol for a reanalysis of published data based on systematic reviews of diagnostic test accuracy.
Zan X; Wang Y; Shi J; Zhao L; Zhao Y; Liu R; Zhou Y; Wan Y;
Medicine (Baltimore); 2019 Jun; 98(24):e16028. PubMed ID: 31192957
[TBL] [Abstract][Full Text] [Related]
7. The value of biomarkers in colorectal cancer: Protocol for an overview and a secondary analysis of systematic reviews of diagnostic test accuracy.
Wang J; Liang W; Wang X; Min G; Chen W; Wang H; Yao N; Wang J;
Medicine (Baltimore); 2019 Jun; 98(24):e16034. PubMed ID: 31192959
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of biomarkers for ovarian cancer: Protocol for an overview, evidence mapping, and adjusted indirect comparisons.
Hua J; Liu J; Hua M; Cai R; Li M; Wang J; Wang J;
Medicine (Baltimore); 2019 May; 98(18):e15508. PubMed ID: 31045839
[TBL] [Abstract][Full Text] [Related]
9. Plasma cell-free DNA chromosomal instability analysis by low-pass whole-genome sequencing to monitor breast cancer relapse.
Zhou H; Wang XJ; Jiang X; Qian Z; Chen T; Hu Y; Chen ZH; Gao Y; Wang R; Ye WW; Cao WM
Breast Cancer Res Treat; 2019 Nov; 178(1):63-73. PubMed ID: 31364001
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers for detecting prostate cancer: Protocol for an umbrella review with integrated network meta-analysis.
Jia J; Sun Y; Ren J; Li M; Wang J; Li H;
Medicine (Baltimore); 2019 Jul; 98(30):e16517. PubMed ID: 31348264
[TBL] [Abstract][Full Text] [Related]
12. Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis.
Nguyen THN; Nguyen TTN; Nguyen TTM; Nguyen LHM; Huynh LH; Phan HN; Nguyen HT
Breast Cancer Res Treat; 2022 Nov; 196(1):1-15. PubMed ID: 36085533
[TBL] [Abstract][Full Text] [Related]
13. APC gene promoter aberrant methylation in serum as a biomarker for breast cancer diagnosis: A meta-analysis.
Qian X; Ruan L
Thorac Cancer; 2018 Feb; 9(2):284-290. PubMed ID: 29297603
[TBL] [Abstract][Full Text] [Related]
14. APC gene promoter methylation as a potential biomarker for lung cancer diagnosis: A meta-analysis.
Liu F; Lu X; Zhou X; Huang H
Thorac Cancer; 2021 Nov; 12(21):2907-2913. PubMed ID: 34545707
[TBL] [Abstract][Full Text] [Related]
15. CA153 in Breast Secretions as a Potential Molecular Marker for Diagnosing Breast Cancer: A Meta Analysis.
Tang S; Wei L; Sun Y; Zhou F; Zhu S; Yang R; Huang Y; Zhang H; Xu H; Yang J
PLoS One; 2016; 11(9):e0163030. PubMed ID: 27636552
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic significance assessment of the circulating cell-free DNA in ovarian cancer: An updated meta-analysis.
Li B; Pu K; Ge L; Wu X
Gene; 2019 Sep; 714():143993. PubMed ID: 31330238
[TBL] [Abstract][Full Text] [Related]
17. Comparison of value of biomarkers in diagnosing lung cancer: An overview of systematic reviews protocol.
Wu F; Wang H; Tao H; Huang H; Zhang L; Wu D; Wan Y;
Medicine (Baltimore); 2019 May; 98(19):e15525. PubMed ID: 31083197
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA Dysregulation in Early Breast Cancer Diagnosis: A Systematic Review and Meta-Analysis.
Garrido-Palacios A; Rojas Carvajal AM; Núñez-Negrillo AM; Cortés-Martín J; Sánchez-García JC; Aguilar-Cordero MJ
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175974
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic value of miR-200 family in breast cancer: A meta-analysis and systematic review.
Thi Chung Duong T; Nguyen THN; Thi Ngoc Nguyen T; Huynh LH; Ngo HP; Thi Nguyen H
Cancer Epidemiol; 2022 Apr; 77():102097. PubMed ID: 35030348
[TBL] [Abstract][Full Text] [Related]
20. Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast.
Lee A; Kim Y; Han K; Kang CS; Jeon HM; Shim SI
Arch Pathol Lab Med; 2004 Nov; 128(11):1251-6. PubMed ID: 15508191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
